Results 11 to 20 of about 445,193 (314)

Long-term preoperative glycemic control restored the perioperative neutrophilic phagocytosis activity in diabetic mice

open access: yesBMC Endocrine Disorders, 2020
Background The risk of surgical site infection has been reported to be higher in patients with poorly controlled diabetes. Since chronic hyperglycemia impairs neutrophil functions, preoperative glycemic control may restore neutrophil function.
Daichi Fujimoto   +4 more
doaj   +1 more source

Can We Predict the Insulin Therapy Need and Early Postpartum Prediabetes in Patients with Gestational Diabetes Mellitus?

open access: yesClinical Diabetology, 2023
OBJECTIVE: The authors aimed to identify risk factors for insulin therapy need and for the development of postpartum prediabetes in women with gestational diabetes mellitus (GDM).
Magdalena Dolecka-Ślusarczyk   +5 more
doaj   +1 more source

Adherence to Insulin Therapy [PDF]

open access: yesDiabetes Spectrum, 2016
IN BRIEF Six million people with diabetes use insulin either alone or in combination with an oral medication. Many barriers exist that lead to poor adherence with insulin. However, there is an underwhelming amount of data on interventions to address these barriers and improve insulin adherence.
Sarbacker, G. Blair   +1 more
openaire   +2 more sources

Continuous insulin therapy versus multiple insulin injections in the management of type 1 diabetes: a longitutinal study

open access: yesRevista Paulista de Pediatria, 2016
Objective: To compare multiple doses of insulin and continuous insulin infusion therapy as treatment for type 1 diabetes mellitus. Methods: 40 patients with type 1 diabetes mellitus (21 female) with ages between 10 and 20 years (mean=14.2) and mean ...
Maria Estela Bellini Ribeiro   +3 more
doaj   +1 more source

Blood Glucose Meter Buying Behavior of Diabetic Patients: Factors Influencing Purchase

open access: yesFrontiers in Public Health, 2022
ObjectiveTo understand the blood glucose meter buying behavior of type 2 diabetic patients with poor glycemic control (two or more HbA1c ≥ 8% during visits in one year) and identify factors influencing it.MethodsA survey was conducted among 585 diabetic ...
Bai-ling Pan   +3 more
doaj   +1 more source

Management and efficacy of intensified insulin therapy starting in outpatients [PDF]

open access: yes, 1989
Diabetic patients under multiple injection insulin therapy (i.e., intensified insulin therapy, IIT) usually start this treatment during hospitalization. We report here on the logistics, efficacy, and safety of IIT, started in outpatients.
Winkelmann, W.   +11 more
core   +1 more source

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience [PDF]

open access: yes, 2017
Basal insulin therapy can improve glycemic control in people with type 2 diabetes. However, timely initiation, optimal titration, and proper adherence to prescribed basal insulin regimens are necessary to achieve optimal glycemic control.
Sony Wibisono Mudjanarko   +10 more
core   +2 more sources

Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes [PDF]

open access: yes, 2004
Objectives: To assess the clinical and cost-effectiveness of continuous subcutaneous insulin infusion (CSII) compared with multiple daily injections (MDI) in the delivery of intensive insulin therapy for the treatment of diabetes mellitus.
Green, C.   +9 more
core   +1 more source

Data on insulin therapy refusal among type II diabetes mellitus patients in Mashhad, Iran

open access: yesData in Brief, 2018
Insulin has been considered as a therapy option of last resort in type 2 diabetes (T2DM) management. Delay in insulin therapy is common in these patients.
Zahra Mostafavian   +4 more
doaj   +1 more source

The evolution of insulin therapy [PDF]

open access: yesDiabetes Research and Clinical Practice, 2021
Evolution in medicine is generally driven by clinical need, hand in hand with opportunities generated by novel chemical and mechanical engineering technologies. Since 1921 that has been a continuing paradigm for insulin therapy, some advances being a continual process, and others arising from external scientific or engineering developments ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy